Skip to main content

Table 2 Description of toxicities during CTRT

From: Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survival

Type of toxicity

Grade 3

N (%)

Grade 4

N (%)

Vomiting

5 (25%)

2 (10%)

Fatigue

2 (10%)

-

Hypokalemia

2 (10%)

-

Anorexia

1 (5%)

-

Diarrhea

1 (5%)

-

Nausea

4 (20%)

-

Stomatitis

1 (5%)

-

Abdominal pain

1 (5%)

1 (5%)

Dyspepsia

1 (5%)

-

Hyperglycemia

1 (5%)

-

Deterioration of general condition

1 (5%)

-

Hypotension

-

1 (5%)

Gastrointestinal bleeding

-

1 (5%)